Both Bristol-Myers Squibb and Celgene constantly outperformed their peers when it comes to R&D expenses. Peer Group composes of Bristol-Myers Squibb, Celgene, Novartis, Pfizer, Merck, Gilead Sciences, AstraZeneca, AbbVie and Amgen. Source: Bloomberg, Bristol-Myers Squibb, Celgene